搜索临床试验以:Pulmonary Multidrug-Resistant Tuberculosis (MDR TB)
总计13580个结果
-
Karolinska InstitutetFudan University; University Medical Center Groningen完全的
-
Brigham and Women's HospitalHarvard School of Public Health (HSPH); Mclean Hospital完全的
-
Shanghai Pulmonary Hospital, Shanghai, ChinaHuashan Hospital; Shanghai Public Health Clinical Center; No.85 Hospital, Changning, Shanghai,...招聘中
-
University of North Carolina, Chapel HillCenters for Disease Control and Prevention; Centre for Infectious Disease Research in Zambia完全的
-
ASST Fatebenefratelli Sacco未知
-
Research Center BorstelLudwig-Maximilians - University of Munich; "Marius Nasta" Pulmonology Institute完全的
-
Kent Hospital, Rhode IslandNational Institute of General Medical Sciences (NIGMS)主动,不招人
-
Oncurious NVBeat Childhood Cancer完全的
-
Research Institute for Biological Safety ProblemsResearch Institute of Influenza, Russia; Ministry of Health, Kazakhstan完全的
-
University of Cape TownImperial College London; Institute of Tropical Medicine, Belgium; European and Developing Countries... 和其他合作者完全的
-
St George's Healthcare NHS Trust未知
-
Farman Ullah KhanPakistan Institute of Medical Sciences; Shaheed Zulfiqar Ali Bhutto Medical University Islamabad... 和其他合作者未知
-
Foundation for Innovative New Diagnostics, SwitzerlandUniversidad Peruana Cayetano Heredia; Burnet Institute; National Institute for Research in Tuberculosis... 和其他合作者完全的
-
Statens Serum Institut完全的
-
Tuberculosis Clinical Diagnostics Research ConsortiumUniversity of Cape Town未知
-
Centers for Disease Control and PreventionJohns Hopkins University; Sanofi; University of Stellenbosch; University of Cape Town; Washington... 和其他合作者招聘中
-
Johns Hopkins Bloomberg School of Public HealthNational Institute of Mental Health (NIMH); TB/HIV Care; Community Media Trust完全的
-
University of North Carolina, Chapel HillCentre for Infectious Disease Research in Zambia完全的
-
ANRS, Emerging Infectious DiseasesNew York University; Université Montpellier; Expertise France; Haiphong University of Medicine and... 和其他合作者招聘中
-
Global Alliance for TB Drug Development完全的利奈唑胺加贝达喹啉和 Pretomanid 的各种剂量和治疗持续时间在患有肺结核、广泛耐药结核病、广泛耐药结核病前或无反应/不耐受耐多药结核病的参与者中的安全性和有效性 (ZeNix) (ZeNix)结核 | 肺结核 | 结核病,多重耐药 | 广泛耐药结核病 | 结核病、耐多药 | 广泛耐药结核病 | 广泛耐药结核前南非, 俄罗斯联邦, 乔治亚州, 摩尔多瓦共和国
-
Case Western Reserve UniversityThrasher Research Fund完全的艾滋病毒感染 | 结核 | 潜伏性结核感染南非
-
National Institute of Allergy and Infectious Diseases...University of Pennsylvania; Emory University; University of Florida; Aurum Institute完全的
-
Swiss Federal Institute of TechnologySwiss Tropical & Public Health Institute; Ifakara Health Institute完全的
-
University of StellenboschThrasher Research Fund未知
-
University of Massachusetts, WorcesterNational Institute of Allergy and Infectious Diseases (NIAID); Aurum Institute; University of... 和其他合作者招聘中
-
University Children's Hospital BaselUniversity Hospital, Geneva; University Hospital Inselspital, Berne; Kantonsspital Aarau; University... 和其他合作者招聘中
-
Otsuka Pharmaceutical Development & Commercialization...终止
-
University of Southern DenmarkOdense University Hospital; University of Ghana; Odense Patient Data Explorative Network; National... 和其他合作者完全的
-
Johns Hopkins Bloomberg School of Public HealthNational Institute of Mental Health (NIMH); Unity Health Toronto; TB/HIV Care招聘中
-
Johns Hopkins Bloomberg School of Public HealthUniversity of California, San Francisco; University of Toronto; National Institute for Communicable... 和其他合作者完全的
-
Chinese University of Hong KongGuangzhou Institute of Respiratory Disease完全的
-
Immunitor LLCUniversity of Stellenbosch; Lisichansk Regional Tuberculosis Dispensary; National Medical University... 和其他合作者完全的
-
Massachusetts General HospitalNational Institute of Allergy and Infectious Diseases (NIAID); AIDS Healthcare Foundation完全的